Özalp Kızılay Deniz, Özen Samim
Ege University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, İzmir, Turkey
J Clin Res Pediatr Endocrinol. 2024 Dec 4;16(4):401-410. doi: 10.4274/jcrpe.galenos.2024.2024-3-3. Epub 2024 Apr 29.
Disorders of sex development (DSD) are a clinically and genetically highly heterogeneous group of congenital disorders. The most accurate and rapid diagnosis may be possible with a complementary multidisciplinary diagnostic approach, including comprehensive clinical, hormonal, and genetic investigations. Rapid and accurate diagnosis of DSD requires urgency in terms of gender selection and management of the case. Despite the genetic tests performed in current daily practice, the genetic cause is still not elucidated in a significant proportion of cases. Karyotype analysis can be used as a standard for sex chromosome identification. In addition, quantitative fluorescent-polymerase chain reaction or fluorescence in situ hybridization analysis can be used for faster and more cost-effective detection of the sex chromosome and SRY gene. Multiplex ligation-dependent probe amplification, single-gene sequence analysis, next-generation sequence analysis (NGSA), targeted NGSA, whole-exome sequencing, and whole-genome sequencing analyses can be performed according to preliminary diagnoses. Microarray analysis, including array comparative genomic hybridization and single nucleotide polymorphism array, should be performed in cases with syndromic findings and if no pathology is detected with other tests. In DSD cases, the use of optical genome mapping and techniques, which will probably be in daily practice in the near future, may be considered. In conclusion, the clinical and genetic diagnosis of DSD is difficult, and molecular genetic diagnosis is often not available. This has psychosocial and health implications for patients and their families. New genetic techniques, especially those targeting the whole genome, may provide a better understanding of DSD through the identification of little-known genetic causes. This review focuses on conventional genetic and next-generation genetic techniques used in the genetic diagnosis of DSD, as well as possible genetic diagnostic techniques and approaches that may be used in routine practice in the near future.
性发育障碍(DSD)是一组临床和遗传上高度异质的先天性疾病。采用包括全面临床、激素和基因检测在内的多学科互补诊断方法,可能实现最准确、快速的诊断。DSD的快速准确诊断在性别选择和病例管理方面具有紧迫性。尽管在当前日常实践中进行了基因检测,但在相当一部分病例中,遗传病因仍未阐明。核型分析可作为性染色体鉴定的标准。此外,定量荧光聚合酶链反应或荧光原位杂交分析可用于更快、更具成本效益地检测性染色体和SRY基因。可根据初步诊断进行多重连接依赖探针扩增、单基因序列分析、下一代测序分析(NGSA)、靶向NGSA、全外显子测序和全基因组测序分析。对于有综合征表现且其他检测未发现病理情况的病例,应进行微阵列分析,包括阵列比较基因组杂交和单核苷酸多态性阵列。在DSD病例中,可考虑使用光学基因组图谱技术,这些技术可能在不久的将来应用于日常实践。总之,DSD的临床和基因诊断困难,分子基因诊断往往无法实现。这对患者及其家庭具有心理社会和健康方面的影响。新的基因技术,尤其是那些针对全基因组的技术,可能通过识别鲜为人知的遗传病因,更好地理解DSD。本综述重点介绍了用于DSD基因诊断的传统基因技术和下一代基因技术,以及可能在不久的将来用于常规实践的基因诊断技术和方法。